Penn Capital Management Company LLC Makes New Investment in Aehr Test Systems $AEHR

Penn Capital Management Company LLC bought a new stake in Aehr Test Systems (NASDAQ:AEHR - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 150,547 shares of the semiconductor company's stock, valued at approximately $14,476,000. Penn Capital Management Company LLC owned about 0.46% of Aehr Test Systems at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd bought a new stake in shares of Aehr Test Systems during the fourth quarter worth about $25,000. Advocate Investing Services LLC bought a new position in Aehr Test Systems in the 2nd quarter valued at approximately $26,000. Sunbelt Securities Inc. acquired a new stake in Aehr Test Systems during the 3rd quarter worth approximately $27,000. State of Wyoming bought a new stake in Aehr Test Systems during the 2nd quarter worth approximately $28,000. Finally, KBC Group NV bought a new stake in Aehr Test Systems during the 1st quarter worth approximately $30,000. 69.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on AEHR shares. Lake Street Capital reaffirmed a "buy" rating and set a $110.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Wall Street Zen upgraded Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Zacks Research raised Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a report on Friday, July 17th. Craig Hallum reiterated a "buy" rating and issued a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Finally, Weiss Ratings cut Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a research note on Wednesday, July 29th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $136.67.

Aehr Test Systems News Roundup

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Stock Performance

NASDAQ:AEHR opened at $134.06 on Friday. Aehr Test Systems has a 52 week low of $16.38 and a 52 week high of $147.40. The firm's fifty day moving average is $92.83 and its 200-day moving average is $71.45. The firm has a market cap of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10.

Insiders Place Their Bets

In other Aehr Test Systems news, Director Rhea J. Posedel sold 8,413 shares of the company's stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $130.00, for a total transaction of $1,093,690.00. Following the sale, the director owned 387,962 shares of the company's stock, valued at approximately $50,435,060. This represents a 2.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Howard T. Slayen sold 20,000 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $108.30, for a total value of $2,166,000.00. Following the sale, the director owned 146,367 shares of the company's stock, valued at approximately $15,851,546.10. The trade was a 12.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 109,475 shares of company stock valued at $13,827,160 over the last quarter. Company insiders own 6.80% of the company's stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source